Adherium Ltd. | Income Statement

Fiscal year is July-June. All values AUD Thousands.
2016
2017
2018
Sales/Revenue
2,100.80
2,347.00
5,900.00
Cost of Goods Sold (COGS) incl. D&A
1,068.80
1,186.00
1,100.00
Gross Income
1,032.00
1,161.00
4,800.00
SG&A Expense
7,716.80
14,993.00
14,900.00
EBIT
6,684.80
13,832.00
10,100.00
Non Operating Income/Expense
232.00
409.00
800.00
Interest Expense
303.20
-
-
Pretax Income
6,308.00
12,810.00
-
Consolidated Net Income
6,308.00
12,810.00
9,300.00
Net Income
6,308.00
12,810.00
9,300.00
Net Income After Extraordinaries
6,308.00
12,810.00
9,300.00
Net Income Available to Common
6,308.00
12,810.00
9,300.00
EPS (Basic)
0.05
0.08
0.05
Basic Shares Outstanding
119,606.30
169,431.00
-
EPS (Diluted)
0.05
0.08
-
Diluted Shares Outstanding
119,606.30
169,431.00
-
EBITDA
6,563.20
13,562.00
-
Non-Operating Interest Income
448.00
613.00
-

About Adherium

View Profile
Address
204 Quay Street
Auckland AU 1010
New Zealand
Employees -
Website http://www.adherium.com
Updated 07/08/2019
Adherium Ltd. engages in the development, manufacture, and supply of digital health technologies which addresses suboptimal medicine use in chronic disease. Its product platform Smartinhaler, comprises of medical devices which monitors inhaler actuation and provides audio and visual medication reminders; and SmartinhalerLive software, which integrates data from the Smartinhaler into a usable form. The company was founded by Garth Sutherland on April 7, 2015 and is headquartered in Auckland, New Zealand.